![Editors in Conversation artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts113/v4/b8/68/dd/b868dd9f-5a51-91c9-fb51-f8d1567e8465/mza_5151066038574592298.jpg/100x100bb.jpg)
The Antimicrobial Resistance Leadership Group (ARLG) - (AAC ed.)
Editors in Conversation
English - November 30, 2020 22:35 - 46 minutes - 32.2 MB - ★★★★ - 10 ratingsLife Sciences Science Health & Fitness Medicine asm for fox interviews jeff magazine microbe microbiology news science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
ARLG is changing the field of clinical research in antimicrobial resistance. We will talk with the Principal Investigators of the ARLG to discuss their strategy
Objectives:
• Review the history and accomplishments of ARLG
• Discuss the missions of ARLG including training new clinical investigators focused on antibiotic resistance
• Comment of the future of ARLG and clinical research on antibiotic resistance
Joining me to talk about ARLG are the principal investigators of this ambitious effort:
• Dr. Vance Fowler: Professor of Medicine, Florence McAlister Distinguished Professor of Medicine, Professor in Molecular Genetics and Microbiology, Duke University.
• Dr. Henry “Chip” Chambers: Professor of Medicine, Emeritus. University of California, San Francisco
Visit aac.asm.org to read the current issue.